Journal of Atrial Fibrillation

Upcoming Events

1st International Symposium on Left Atrial Appendage

InterContinental Hotel, Kansas City, MO March 1-2, 2013 Course Directors

Dhanunjaya Lakkireddy, MD, University of Kansas Hospital, Kansas City, KS David Holmes, MD, Mayo Clinic, Rochester, MN Saibal Kar, MD, Cedars Sinai Hospital, Los Angeles, CA Andrea Natale, MD, Texas Cardiac Arrhythmia Institute, Austin, TX Overview The purpose of this symposium is to update medical practitioners on the future of Left Atrial Appendage (LAA) Procedures. Participants will learn about various research studies regarding Left Atrial Appendage exclusion that includes both occlusion and ligation types of devices and gain a better understanding of the role that the LAA plays in atrial arrhythmias. An evolution of percutaneous techniques in LAA occlusion or exclusion will be discussed. An overview of the role of cardiac imaging in Left Atrial Appendage exclusion will be reviewed. The balance of anticoagulation and bleeding in the high risk patient population will be provided. A variety of topics will provide specialists and generalists an update on the evolution of left atrial appendage strategies and patient care.

Target Audience The International Symposium on Left Atrial Appendage is designed for physicians, nurses, and allied health professionals in the elds of electrophysiology, cardiology, family and internal medicine.

Objectives At the completion of this symposium, participants should be able to: • Demonstrate an understanding of the left atrial appendage (LAA) including the anatomy and pathophysiology. • Describe systemic thromboembolization and the role of LAA in patients with atrial brillation.

www.jafib.com

137

• Express a working knowledge of the role of the left atrial appendage in atrial arrhythmias origin and maintenance. • Examine LAA ligation and occlusion technology. • Discuss the past, present and future of surgical left atrial appendage exclusion. • Evaluate the use of LAA ligation as an adjunctive therapy for AF ablation. • Review the role of oral anticoagulation in stroke prophylaxis. • Understand the systemic side eects of LAA ligation/occlusion technologies. • Discuss practical issues related to procedural performance. • Appropriate case selections for pharmacological and interventional therapies for stroke prophylaxis.

Dec 2012-Jan 2013 | Vol 5 | Issue 4

Journal of Atrial Fibrillation

Upcoming Events

Acknowledgements Financial contributions and supporters of this program will be acknowledged in print at the symposium.

Accreditation All participants are required to sign attendance rosters at the beginning of each day. A certicate of completion will be provided to all activity participants based on documentation of actual attendance time, meeting minimum attendance requirements specic to the activity, and payment in full. If you are not paid in full, your certicate will be mailed to you upon receipt of payment. Physicians: The University of Kansas Medical Center Oce of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The KU Medi-

www.jafib.com

138

cal Center Oce of Continuing Medical Education designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses: Up to 16.16 contact hours will be awarded to all individuals based on documentation of actual attendance time, meeting minimum attendance requirements specic to the activity, and payment in full. University of Kansas School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Exhibits Commercial vendors are invited to exhibit at this meeting. Limited exhibit space will be available. Call Julie Darrington at 913-588-4581 or e-mail [email protected] for an application or more information.

Dec 2012-Jan 2013 | Vol 5 | Issue 4

Journal of Atrial Fibrillation

Upcoming Events Course Directors

Dhanunjaya Lakkireddy, MD, FACC, FHRS, Director, Center for Excellence in Atrial Fibrillation & Electrophysiology Research; Professor of Internal Medicine, Mid-America Cardiology, University of Kansas Hospital, Kansas City, KS

Saibal Kar, MD, FACC, FSCAI, Director, Cardiovascular Intervention Research, Cedars Sinai Hospital; Director, Interventional Cardiac Research and Associate Professor of Medicine, David Gelfen School of Medicine, UCLA, Los Angeles, CA

David Holmes, MD, FACC, FSCAI, Professor of Medicine and Consultant, Department of Internal Medicine, Division of Cardiovascular Diseases, Former President of the American College of Cardiology (ACC), Mayo Clinic, Rochester, MN Andrea Natale, MD, FACC, FHRS, FESC, Executive Medical Director, Texas Cardiac Arrhythmia Institute, Austin, TX; Consulting Professor, Division of Cardiology, Stanford University, Palo Alto, CA; Director, Interventional Electrophysiology, Scripps Clinic, La Jolla, CA

Symposium Faculty Sam Asirvatham, MD, FACC, FHRS Professor of Medicine and Pediatrics, Departments of Cardiovascular Disease & Pediatric & Adolescent Medicine, Mayo Clinic, Rochester, MN Loren Berenbom, MD, FACC, FHRS Professor of Medicine; Cardiology Director, Bloch Heart Rhythm Center, Mid-America Cardiology at University of Kansas Hospital, Kansas City, KS Luigi Di Biase, MD, PhD, FHRS Senior Researcher, Texas Cardiac Arrhythmia Institute, St. David’s Medical Center; Associate Professor, Albert Einstein College of Medicine at Monteore Hospital, New York, NY Matthew Earnest, MD, FACC, FSCAI Clinical Assistant Professor of Medicine, Cardiology, Mid-America Cardiology at University of Kansas Hospital, Kansas City, KS Ted Feldman, MD, FSCAI Director, Cardiac Catheterization Laboratory, NorthShore University HealthSystem, Evanston Hospital, Evanston, IL A. Marc Gillinov, MD, FACC, FAHA Institute Experience Ocer, Heart & Vascular Institute Cleveland Clinic, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH Swaminatha Gurudevan, MD, FACC, FASE, FSCCT, Assistant Professor of Medicine;

www.jafib.com

139

Cardiologist, Cedars-Sinai Heart Institute, Los Angeles, CA Rodney Horton, MD, FACC, FHRS Cardiac Electrophysiologist, Texas Cardiac Arrhythmia Institute, Austin, TX Réda Ibrahim, MD, CSPQ, FRCPC Interventional Cardiologist, Montreal Heart Institute; Associate Professor of Medicine, Universite de Montreal, Montreal Heart Institute, Quebec City, Quebec Randall Lee, PhD, MD UCSF Eli and Edith Broad Center of Regeneration Medicine and Stem Cell Research, University California San Francisco, San Francisco, CA Michael Mack, MD, FACC Director, Cardiovascular Research and Cardiovascular Medicine, The Heart Hospital at Baylor, Plano, TX Moussa Mansour, MD, FACC, FHRS Assistant Professor in Medicine, Cardiac Electrophysiology Laboratory; Director of Atrial Fibrillation Program, Massachusetts General Hospital, Boston, MA James Min, MD, FACC Associate Professor of Medicine, Imaging and Biomedical Sciences; Director, Cardiac Imaging Research; Co-Director, Cardiac Imaging, Cedars Sinai Medical Center, Los Angeles, CA

Dec 2012-Jan 2013 | Vol 5 | Issue 4

Journal of Atrial Fibrillation

Upcoming Events

Greg Muehlebach, MD, FACS Director of Thoracic Surgery; Clinical Assistant Professor, Department of Cardiovascular Disease, Mid-America Thoracic and Cardiovascular Surgeons, University of Kansas Hospital, Kansas City, KS Jayant Nath, MD Cardiologist; Assistant Professor Cardiovascular Diseases, Mid-America Cardiology at University of Kansas Hospital, Kansas City, KS Matthew Price, MD, FACC Director, Cardiac Catheterization Laboratory, Scripps Clinic Torrey Pines, La Jolla, CA Vijay Swarup, MD, FACC, FHRS Director Cardiac Electrophysiology, Arizona Heart Rhythm Institute, Phoenix, AZ Peter Tadros, MD, FACC, FSCAI, FASE Assistant Professor of Medicine; Cardiology Director, Interventional Cardiology Laboratory, Mid-America Cardiology at University of Kansas Hospital, Kansas City, KS

Zoltan Turi, MD, FACC, FSCAI Director, Cooper Vascular Center; Director, Cooper Structural Heart Disease Program; Clinical Cardiologist, Cooper University, Cherry Hill, NJ Miguel Valderrábano, MD, FACC Chief, Division of Cardiac Electrophysiology; Associate Professor of Medicine, Weill Cornell Medical College of Cornell University, Methodist DeBakey Cardiology Associates, Houston, TX Brian Whisenant, MD Medical Director of Intermountain Medical Center’s Structural Heart Disease Program, Intermountain Heart Institute, Murray, UT Richard Whitlock, MD Cardiovascular Surgery, Population Health Research Institute at McMaster University, Hamilton, Ontario Trip Zorn, MD Clinical Assistant Professor, Cardiothoracic Surgery, Mid-America Thoracic and Cardiovascular Surgeons, University of Kansas Hospital, Kansas City, KS

Planning Committee Donita Atkins, RN, BSN, CCRC, EP Research Manager

tion & Electrophysiology Research, Professor of Medicine, University of Kansas Hospital

Ryan Ferrell, MD, FACC, FACP, Assistant Clinical Professor, University of Kansas Hospital

Barbara Gill MacArthur, RN, MN, FAAN, Vice President of Cardiac Services

Mary Gambino, RN, PhD, Assistant Dean for Community Aairs, Director of Nursing Continuing Education, University of Kansas School of Nursing Dhanunjaya Lakkireddy, MD, FACC, FHRS, Director, Center for Excellence in AtrialFibrilla-

www.jafib.com

140

Marla Sutton, MS, Senior Program Manager, Oce of Continuing Education, University of Kansas Medical Center Renee Walters, RN, MSN, CCRN, EP Nurse Manager University of Kansas Hospital and University of Kansas Medical Center, Kansas City, KS

Dec 2012-Jan 2013 | Vol 5 | Issue 4

1st International Symposium on Left Atrial Appendage.

1st International Symposium on Left Atrial Appendage. - PDF Download Free
373KB Sizes 1 Downloads 13 Views